FOCUS INITIATIVES
Enhancing Pharmaceutical TherapiesInnovation and a commitment to advancing research help BD remain at the leading edge of drug discovery, production and delivery. Discovery and Development BD’s contributions to drug discovery can be traced to the very first commercial flow cytometer, which the Company brought to market in 1973. Today, major pharmaceutical companies as well as medical and academic research centers the world over use BD flow cytometry platforms – including cell sorters, analyzers, software and reagents – to identify cells and better understand their functions and the effects new drug candidates have on them. BD also helps pharmaceutical and biotechnology customers and partners develop new medicines tailored to specific patient sub-populations by collaborating on the development of biomarkers and companion diagnostic assays. Biopharmaceutical Production With over 50 years of expertise in bacterial fermentation and mammalian cell culture, BD Biosciences – Advanced Bioprocessing products—including Difco™ and BBL™ brand supplements and media—are used as critical components in the production of some of the most widely used drugs and vaccines on the global market today. BD continues to drive innovation through chemically defined supplements that help boost performance, reduce risk and increase consistency. BD chemically defined, animal-free supplements are designed to eliminate unnecessary constituents and potential inhibitors to maximize cellular activation and protein production. The result is protein quality and yield comparable to peptone supplementation — without the risks associated with undefined materials. BD’s animal-free/antibiotic-free (AF2) facility sets a new standard for safety, quality and regulatory compliance for cell culture media. This new plant will manufacture products that are controlled for animal-origin component raw materials to the tertiary level -- the most stringent level of control available, significantly reducing the risks associated with mixed-use plants. At BD we’re rethinking cell culture media and supplementation so you can redefine consistency and reduce risk within your manufacturing process. Visit www.bdbiosciences.com/advbio (US) to learn more. Drug Delivery When the most demanding pharmaceutical and biotechnology companies look for better ways to deliver injectable drugs and vaccines, they turn to BD – the world’s leading provider of prefillable drug delivery systems. To meet the growing demand for BD Hypak™ SCF – sterile, clean, ready-to-fill – Glass Prefillable Syringes, BD is making significant investments in high-volume manufacturing, while also enhancing quality and providing customized systems that respond to the specific requirements of each drug or vaccine. BD also continues to invest in advanced injectable drug delivery systems by developing novel prefillable "Micro-Delivery" devices and self-injection devices for chronic therapies.
|
Researchers use BD™ Phosflow technology to analyze cell signaling pathways to understand how experimental drugs might impact these pathways and inhibit the spread of disease. BD Cytometric Bead Arrays allow researchers to analyze multiple markers at the same time, increasing efficiency and delivering more results from smaller samples.